Home Innovation That Matters

Innovation That Matters

Novira’s Novel Approach to Anti-HBV Drug Discovery

For this month’s Innovation That Matters feature, we interviewed Dr. Osvaldo (Lalo) Flores, CSO of Novira Therapeutics, a leading biotech based in Philadelphia, PA, which is testing novel approaches to anti-hepatitis B (anti-HBV) drug discovery.  Hepatitis B infection presents a significant unmet medical need.  An...

Imbruvica and Its Impact on Patients

For this month’s Innovation That Matters, we interviewed Heow Tan, Chief of Quality and Technical Operations at Pharmacyclics.  Tan joined Pharmacyclics in 2012 and has headed their Global Quality, CMC Development, Global Manufacturing, Supply Chain, and International Operations. Pharmacyclics lead product, ibrutinib, with the...

Fighting Counterfeit Medicines with TruTag Technologies

Did you know that 10% of all medicines are estimated to be counterfeit? Counterfeit medicines are found everywhere in the world, putting lives at risk and undermining the credibility of pharmaceutical products.  Online pharmacies are proliferating, and 50% of prescription medicines that are bought...

Hua Medicine Breaking New Ground

This month's Innovation That Matters features an interview Dr. Li Chen, CEO of Hua Medicine.  Chen and his colleagues at Hua had much to celebrate in November as their novel Type II diabetes treatment entered clinical trials in China. This milestone marks the first case in China...

A Conversation with Carl Firth, CEO of ASLAN Pharmaceuticals

Since setting up in 2010, Singapore-based ASLAN Pharmaceuticals has shaken up drug development with its innovative, virtual approach to advancing therapeutic candidates. Fresh from winning the Red Herring Top 100 Asia Award 2013, ASLAN CEO Dr. Carl Firth spoke about the company’s model, drug...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics CGMP...

We are pleased to announce that the U.S. Food and Drug Administration has completed the Pre-License Inspection (PLI) of WuXi Biologics cGMP manufacturing facilities...